Ultragenyx Pharmaceutical Inc.

EMERALD MUTUAL FUND ADVISERS TRUST RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

120,505

Value ($000)

2,772

Weight

0.1%

2014 Q1 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	2,772	0.1%	120,505	12/31/2025
2025 Q3	10/30/2025	7,303	0.4%	242,802	9/30/2025
2025 Q2	8/4/2025	10,738	0.7%	295,317	6/30/2025
2014 Q2	7/17/2014	1,559	0.1%	34,734	6/30/2014
2014 Q1	4/30/2014	1,101	0.1%	22,530	3/31/2014